Prof Frederick Currell
Director of the Dalton Cumbrian Facility
Impact
1 - 2 out of 2Page size: 20
Supporting Nanobiotix development of NBTXR3, the world’s first nanomedicine to reach market.
Frederick Currell (Participant)
Impact: Health and wellbeing